Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Evaluating soil metal(loid) mobility at large scales is nearly intractable by laboratory experiments. This study uses theory-guided machine learning methods to map ...

Trump’s predecessor, Joe Biden, proposed a rule in late November after Trump won re-election that would have extended coverage of drugs like Zepbound and Wegovy. The rule was not expected to be ...

Wegovy and Zepbound both cost roughly $1,000 before insurance and other rebates. Allowing Medicare to cover those drugs and other weight loss medications could cost $35 billion over nine years ...

Get local news you need to know to start your day with NBC 6's News Headlines newsletter. Wegovy and Zepbound both cost roughly $1,000 before insurance and other rebates. Allowing Medicare to ...

But the Centers for Medicare and Medicaid Services said it may reconsider coverage of those drugs in the future, according to a fact sheet on the rule. The proposal would have given millions more ...

Fuelled by dividends from blockbuster weight-loss drug Wegovy and diabetes treatment Ozempic, Novo Holdings is a life sciences investment powerhouse that manages assets for the Novo Nordisk Foundation ...